Your browser doesn't support javascript.
loading
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response.
Swain, Sandra M; Tang, Gong; Brauer, Heather Ann; Goerlitz, David S; Lucas, Peter C; Robidoux, André; Harris, Brent T; Bandos, Hanna; Ren, Yuqi; Geyer, Charles E; Rastogi, Priya; Mamounas, Eleftherios P; Wolmark, Norman.
Afiliação
  • Swain SM; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC. sms248@georgetown.edu.
  • Tang G; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Brauer HA; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Goerlitz DS; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Lucas PC; NanoString Technologies, Inc., Seattle, Washington.
  • Robidoux A; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC.
  • Harris BT; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Bandos H; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Ren Y; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Geyer CE; Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
  • Rastogi P; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC.
  • Mamounas EP; NSABP Foundation, Pittsburgh, Pennsylvania.
  • Wolmark N; University of Pittsburgh, Pittsburgh, Pennsylvania.
Clin Cancer Res ; 26(16): 4233-4241, 2020 08 15.
Article em En | MEDLINE | ID: mdl-32371537
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Trastuzumab / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article